Report

(a) In general Not later than January 1, 2030, the Secretary of Health and Human Services shall submit to the appropriate committees of Congress a report on the wound care industry, including manufacturers of skin substitute products, wound dressings, and related wound management technologies. Such report shall include an analysis of— (1) the cost of producing skin substitute products in the United States; and (2) patient access to skin substitute products, and the evidence supporting the effectiveness of such products. (b) Definitions In this section: (1) Appropriate committees of Congress The term appropriate committees of Congress means— (A) the Committee on Energy and Commerce and the Committee on Ways and Means of the House of Representatives; and (B) the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate. (2) Skin substitute product The term skin substitute product has the meaning given such term in subparagraph (J) of section 1847A(c)(6) of the Social Security Act (42 U.S.C. 1395w–3a(c)(6)), as added by section 2(c).